Biomm’s novel technology for insulin production is patented in Brazil, countries in Europe, North America and Asia.

Our technology is also suitable for the production of therapeutic proteins such as calcitonin, interferons and growth hormones and has been submitted and approved in many technological due diligencies.

With more than 30 years of experience in biotechnology, we can also develop new processes that can be applied to a variety of different sectors such as the pharmaceutical, biofuels and food industries.

Patents

International patents granted in selected countries such as USA, UK, Germany, Russia, Canada, Brazil and others.